Transgene Biotek Limited, a biotechnology company, provides research and development services for bulk drugs in India. It offers oncology drugs, oral drug delivery, and biogenerics, as well as HIV and multiple sclerosis drugs. The company provides TrabiDHA for use in health food, baby food/formula, health supplement, and chicken and animal feed markets; Tacrolimus, a drug that suppresses the immune system and is used to prevent rejection of transplanted organs; and Orlistat (tetrahydrolipstatin), a lipase inhibitor that blocks about one-third of intestinal fat absorption. The company was incorporated in 1990 and is based in Sangareddy, India.
Metrics to compare | TRBL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTRBLPeersSector | |
---|---|---|---|---|
P/E Ratio | −47.6x | 32.6x | −0.4x | |
PEG Ratio | - | 0.22 | 0.00 | |
Price/Book | 3.2x | 3.7x | 2.6x | |
Price / LTM Sales | 123.5x | 6.1x | 3.1x | |
Upside (Analyst Target) | - | 26.3% | 51.1% | |
Fair Value Upside | Unlock | −10.1% | 8.9% | Unlock |